elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47100134-9FBAD3D5-5558-455D-B2F7-42E9A4DDC6F5
Q47100134-9FBAD3D5-5558-455D-B2F7-42E9A4DDC6F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47100134-9FBAD3D5-5558-455D-B2F7-42E9A4DDC6F5
Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate.
P2860
Q47100134-9FBAD3D5-5558-455D-B2F7-42E9A4DDC6F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47100134-9FBAD3D5-5558-455D-B2F7-42E9A4DDC6F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
851f244f1da89fcc3c29e5cf4b28a787dc81a6ab
P2860
p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation